Your browser doesn't support javascript.
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
Abdullaev, Alisher; Abdurakhimov, Abrorjon; Mirakbarova, Zebinisa; Ibragimova, Shakhnoza; Tsoy, Vladimir; Nuriddinov, Sharofiddin; Dalimova, Dilbar; Turdikulova, Shahlo; Abdurakhmonov, Ibrokhim.
  • Abdullaev A; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Abdurakhimov A; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Mirakbarova Z; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Ibragimova S; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Tsoy V; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Nuriddinov S; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Dalimova D; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Turdikulova S; Center for Advanced Technologies, Tashkent, Uzbekistan.
  • Abdurakhmonov I; Center for Advanced Technologies, Tashkent, Uzbekistan.
PLoS One ; 17(6): e0270314, 2022.
Article in English | MEDLINE | ID: covidwho-1910676
ABSTRACT
Tracking temporal and spatial genomic changes and evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are among the most urgent research topics worldwide, which help to elucidate the coronavirus disease 2019 (COVID-19) pathogenesis and the effect of deleterious variants. Our current study concentrates genetic diversity of SARS-CoV-2 variants in Uzbekistan and their associations with COVID-19 severity. Thirty-nine whole genome sequences (WGS) of SARS-CoV-2 isolated from PCR-positive patients from Tashkent, Uzbekistan for the period of July-August 2021, were generated and further subjected to further genomic analysis. Genome-wide annotations of clinical isolates from our study have revealed a total of 223 nucleotide-level variations including SNPs and 34 deletions at different positions throughout the entire genome of SARS-CoV-2. These changes included two novel mutations at the Nonstructural protein (Nsp) 13 A85P and Nsp12 Y479N, which were unreported previously. There were two groups of co-occurred substitution patterns the missense mutations in the Spike (S) D614G, Open Reading Frame (ORF) 1b P314L, Nsp3 F924, 5`UTRC241T; Nsp3P2046L and Nsp3P2287S, and the synonymous mutations in the Nsp4D2907 (C8986T), Nsp6T3646A and Nsp14A1918V regions, respectively. The "Nextstrain" clustered the largest number of SARS-CoV-2 strains into the Delta clade (n = 32; 82%), followed by two Alpha-originated (n = 4; 10,3%) and 20A (n = 3; 7,7%) clades. Geographically the Delta clade sample sequences were grouped into several clusters with the SARS-CoV genotypes from Russia, Denmark, USA, Egypt and Bangladesh. Phylogenetically, the Delta isolates in our study belong to the two main subclades 21A (56%) and 21J (44%). We found that females were more affected by 21A, whereas males by 21J variant (χ2 = 4.57; p ≤ 0.05, n = 32). The amino acid substitution ORF7aP45L in the Delta isolates found to be significantly associated with disease severity. In conclusion, this study evidenced that Identified novel substitutions Nsp13 A85P and Nsp12 Y479N, have a destabilizing effect, while missense substitution ORF7a P45L significantly associated with disease severity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Female / Humans / Male Country/Region as subject: Asia / Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0270314

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Female / Humans / Male Country/Region as subject: Asia / Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0270314